Status:

COMPLETED

Induction Chemotherapy With TP+5-FU or TP+Cetuximab Followed by Radioimmuptherapy for Locally Advanced or Not Resectable SCCHNN

Lead Sponsor:

Arbeitsgemeinschaft medikamentoese Tumortherapie

Conditions:

Squamous Cell Carcinoma of the Hypopharynx Stage III

Squamous Cell Carcinoma of the Hypopharynx Stage IV

Eligibility:

All Genders

18-75 years

Phase:

PHASE2

Brief Summary

This multicentre, randomised Phase II Pilot Study evaluates the efficacy of docetaxel, cisplatin and 5-fluorouracil or Cetuximab, followed by Cetuximab with radiotherapy.

Detailed Description

It will be evaluated whether 5-FU can be replaced by immunotherapy with cetuximab within a taxane/cisplatin-containing induction-chemotherapy scheme for advanced carcinoma of the head and neck. As 5-F...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Histologically confirmed local advanced squamous cell carcinoma of the Larynx, Hypopharynx, Oropharynx or Cavum oris stage III and IV
  • One measureable lesion (CT oder MR)
  • Age 18 - 75 (including)
  • Performance Score ECOG 0 - 1
  • Exclusion Criteria selected:
  • Distant metastases
  • ECOG Score \>1
  • Prior radiation (Head and neck area)
  • Creatinin Clearance below 60 ml/µl
  • Acute infections
  • Neuropathy grade 3 or 4
  • Myocardial Infarction within the last 12 months
  • Acute coronary syndrome or othe clinically significant cardiovascular diseases

Exclusion

    Key Trial Info

    Start Date :

    May 1 2013

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    January 13 2022

    Estimated Enrollment :

    100 Patients enrolled

    Trial Details

    Trial ID

    NCT01884259

    Start Date

    May 1 2013

    End Date

    January 13 2022

    Last Update

    May 26 2022

    Active Locations (8)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 2 (8 locations)

    1

    Landeskrankenhaus Feldkirch

    Feldkirch, Austria, A-6807

    2

    Landesklinikum Krems

    Krems, Austria, A-3500

    3

    Krankenhaus d. Barmherzigen Schwestern Linz

    Linz, Austria, A-4010

    4

    Kepler Universitätsklinikum, Med Campus III. Klinik für Interne 3 - Schwerpunkt Hämatologie u. Onkologie

    Linz, Austria, A-4021